Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-modular structure of the gene regulatory network for specification and commitment of murine T cells. | Front Immunol | 2023 | 36817475 | PubTator, text mining | PubMed |
| The future of sickle cell disease therapeutics rests in genomics. | Dis Model Mech | 2023 | 36815490 | PubTator, text mining | PubMed |
| SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities. | Mol Cancer | 2023 | 36810086 | PubTator, text mining | PubMed |
| Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation. | PLoS One | 2023 | 36809527 | PubTator, text mining | PubMed |
| Trait - driven analysis of the 2p15p16.1 microdeletion syndrome suggests a complex pattern of interactions between candidate genes. | Genes Genomics | 2023 | 36807877 | PubTator, text mining | PubMed |
| In vivo HSC prime editing rescues sickle cell disease in a mouse model. | Blood | 2023 | 36800642 | PubTator, text mining | PubMed |
| FOXG1 drives transcriptomic networks to specify principal neuron subtypes during the development of the medial pallium. | Sci Adv | 2023 | 36791184 | PubTator, text mining | PubMed |
| Vitamin D and Bone: A Story of Endocrine and Auto/Paracrine Action in Osteoblasts. | Nutrients | 2023 | 36771187 | PubTator, text mining | PubMed |
| Correction to 'The DNA repair function of BCL11A suppresses senescence and promotes continued proliferation of triple-negative breast cancer cells'. | NAR Cancer | 2023 | 36755962 | PubTator, text mining | PubMed |
| A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. | Breast Cancer Res Treat | 2023 | 36735117 | PubTator, text mining | PubMed |
| The Novel Role of the B-Cell Lymphoma/Leukemia 11A (BCL11A) Gene in β-Thalassaemia Treatment. | Cardiovasc Hematol Disord Drug Targets | 2023 | 36734897 | PubTator, text mining | PubMed |
| Therapeutics in paediatric genetic diseases: Current and future landscape. | Singapore Med J | 2023 | 36722512 | PubTator, text mining | PubMed |
| Role of hormones in bone remodeling in the craniofacial complex: A review. | J Oral Biol Craniofac Res | 2023 | 36718389 | PubTator, text mining | PubMed |
| Cell Cycle-Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer. | Biomed Res Int | 2023 | 36718148 | PubTator, text mining | PubMed |
| Recent advancements of miRNAs in the treatment of bone diseases and their delivery potential. | Curr Res Pharmacol Drug Discov | 2023 | 36691422 | PubTator, text mining | PubMed |
| BCL11A Polymorphism in Egyptian Children with β-Thalassemia: Relation to Phenotypic Heterogeneity. | J Pediatr Genet | 2023 | 36684548 | PubTator, text mining | PubMed |
| Molecular Landscape of Tourette's Disorder. | Int J Mol Sci | 2023 | 36674940 | PubTator, text mining | PubMed |
| Recent Advances in Genome-Engineering Strategies. | Genes (Basel) | 2023 | 36672870 | PubTator, text mining | PubMed |
| Better safe than sorry-Whole-genome sequencing indicates that missense variants are significant in susceptibility to COVID-19. | PLoS One | 2023 | 36662838 | PubTator, text mining | PubMed |
| Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies. | CRISPR J | 2023 | 36662546 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=26